Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recent advances in neuromuscular blocking agents.

R R Bartkowski¹

¹Department of Anesthesiology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists

|August 7, 1999

Summary

This summary is machine-generated.

Newer neuromuscular blocking agents aim for fewer side effects and better control than succinylcholine. Development focuses on rapid onset and short duration, improving surgical procedures and patient monitoring.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rapacuronium: first experience in clinical practice.

European journal of anaesthesiology. Supplement·2002

Same author

Measurement of CO2 response with the breath-by-breath automatic acquisition of the breathing pattern and occlusion pressure.

Journal of clinical monitoring·1995

Same author

Intraoperative hemodynamic, renin, and catecholamine responses after prophylactic and intraoperative administration of intravenous enalaprilat.

Anesthesia and analgesia·1995

Same author

Rocuronium onset of action: a comparison with atracurium and vecuronium.

Anesthesia and analgesia·1993

Same author

The pharmacokinetics of droperidol in anesthetized children.

Anesthesia and analgesia·1993

Same author

A comparison of desflurane and isoflurane in prolonged surgery.

Journal of clinical anesthesia·1993

Same journal

Optimizing transitions from direct factor Xa inhibitors to unfractionated heparin therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same journal

Impact of pharmacist involvement on hospital sepsis response teams.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same journal

Attributes of centralized health-system specialty pharmacy clinics: A scoping review using the Donabedian model.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same journal

Zoliflodacin: A novel single-dose oral antibiotic for uncomplicated urogenital gonorrhea.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same journal

Implementation of a paid apprenticeship-model pharmacy technician training program.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same journal

Iodixanol-induced acute generalized exanthematous pustulosis: Cross-reactivity to other iodinated contrast media.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

See all related articles

Area of Science:

Anesthesiology
Pharmacology

Background:

Neuromuscular blocking agents are crucial in anesthesia.
Succinylcholine, while effective, has limitations regarding adverse effects and control.
Development aims to create agents with improved safety and efficacy profiles.

Purpose of the Study:

To discuss the driving factors behind the development of modern neuromuscular blocking agents.
To highlight the goals of achieving faster onset and greater control with fewer adverse effects.
To review specific agents and their characteristics in relation to these goals.

Main Methods:

Review of existing literature on neuromuscular blocking agents.
Discussion of pharmacokinetic and pharmacodynamic properties influencing onset and duration.
Comparison of clinical data for agents like rocuronium and rapacuronium.

Main Results:

Newer agents focus on rapid, organ-independent metabolism or rapid distribution for predictable duration and onset.
Low-potency agents like rocuronium and rapacuronium demonstrate faster onset compared to older agents.
Rapacuronium shows a very rapid onset and short duration, suitable for specific procedures.

Conclusions:

Advances in neuromuscular blocking agents offer faster onset and greater control.
Nondepolarizing relaxants are evolving to provide improved options for anesthesia.
The development trend favors agents with predictable, controllable durations and rapid onset, reducing adverse events.